GeneDx Holdings Corp at Barclays Global Healthcare Conference Transcript
All right, good afternoon, everybody. I'm Luke Sergot. I cover Life Science tools and diagnostics here for Barclays. With me, I have Kevin Feely, CFO of Gene DX. Thanks again for making it, and it's always a pleasure to have you guys here. You guys have been Over the last couple of years just been executing against your commercial targets, right? Continue to build out the platform why don't you just kind of walk us through.
Questions & Answers
The transition that you've had, or not the transition, but the momentum that you've been building over the last couple of years and where you are now and kind of how you're positioned there to jump off into 26 and beyond.
Yeah, and thank you everybody for being here. I mean, GeneDX has operated for 25 years and with a focus specifically in solving the world's hardest to diagnose cases around rare disease.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
